搜索筛选:
搜索耗时4.6451秒,为你在为你在102,285,761篇论文里面共找到 6 篇相符的论文内容
发布年度:
[期刊论文] 作者：ZHENG Yu-huang,ZHANG Chun-ying,
来源：中华医学杂志（英文版） 年份：2004
Background It is internationally accepted that in drug-nave individuals with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection, chro...
[期刊论文] 作者：ZHENG Yu-huang,ZHANG Chun-ying,
来源：中华医学杂志（英文版） 年份：2005
Background It is intationally accepted that in drug-nave individuals with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection, chronic...
A one-year clinical trial using didanosine, stavudine and nevirapine for highly active antiretrovira
[期刊论文] 作者：ZHOU Hua-ying,ZHENG Yu-huang,Z,
来源：中华医学杂志（英文版） 年份：2005
Antiretroviral therapy is a key determinant in the treatment and prevention of human immunodeficiency virus (HIV) infection. Initial treatment for patients wit...
A one-year clinical trial using didanosine, stavudine and nevirapine for highly active antiretrovira
[期刊论文] 作者：ZHOU Hua-ying,ZHENG Yu-huang,ZHANG Chun-ying,DING Pei-pei,ZOU Wen,
来源：中华医学杂志英文版 年份：2005
...
[期刊论文] 作者：ZHENG Yu-huang,ZHANG Chun-ying,HE Yan,ZHOU Hua-ying,ZOU Wen,DING Pei-pei,HUANG Li,LI Hui,
来源：中华医学杂志英文版 年份：2005
...
Efficacy and safety of the long-acting fusion inhibitor albuvirtide in antiretroviral-experienced ad
[期刊论文] 作者：Cheng,Zhao Qing-Xia,Cai Wei-Ping,Wang Min,Lu Hong-Zhou,Chen Yuan-Yuan,Liu Li,Wang Hui,He Yun,Zheng Yu-Huang,
来源：中华医学杂志英文版 年份：2020
Background::Albuvirtide is a once-weekly injectable human immunodeficiency virus (HIV)-1 fusion inhibitor. We present interim data for a phase 3 trial assessing...
相关搜索：
